OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study (NCT03716102)

🧪 Interventions in This Study

• PCI with implantation with DES (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Scottsdale Healthcare — Scottsdale, Arizona
• Northern Michigan Hospital d.b.a McLaren Northern Michigan — Petoskey, Michigan

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Acute Coronary Syndrome

• LEADERS FREE II: BioFreedom™ Pivotal Study — Huntsville, Alabama
• Post Acute Cardiac Event Smoking (PACES) Study — Minneapolis, Minnesota
• DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid — Montreal, Quebec
• Tailoring Post Discharge - Remote Education and Access for Cardiac Health — Winnipeg, Manitoba
• A Prospective Research Investigation of Ischemia Using MCG — Rochester, Minnesota

Explore by condition: All Acute Coronary Syndrome clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.